Results 141 to 150 of about 18,346 (199)

Sequential Transformation of Polycythemia Vera to Myelofibrosis and KMT2A-Rearranged Acute Myeloid Leukemia Treated With Revumenib: A Rare Case of Clonal Evolution. [PDF]

Cureus
Ahmad CM, Kastle RA, Zargarian L, Sawalha Y, Dalia S.   +4 more
europepmc   +1 more source

Novel treatment strategies in acute myeloid leukemia. [PDF]

Blood Res
Simkhada S, Joshi U, Dhakal P.
europepmc   +1 more source

The Histone-Lysine N-Methyltransferase (KMT2) Family in Health and Disease. [PDF]

MedComm (2020)
Wang Q, Bo Z, Zhang Y, Chen Y, Wang Z, Tong S, Xu A, Zhang J, Liu Y.   +8 more
europepmc   +1 more source

Hsa-miR-149-5p targets Men1 to inhibit the progression of gastric cancer through the HSPA6/JNK pathway. [PDF]

Cancer Cell Int
Jiang JX, Zhang SJ, Zhao K, Zheng KT, Wang SH, Chen TD, Wang Z.   +6 more
europepmc   +1 more source

Targeted Therapy in Acute Myeloid Leukemia: Current Approaches and Novel Directions. [PDF]

J Pers Med
Ko KH, Gelfer R, Wheat JC, Cai SF.
europepmc   +1 more source

Menin and BCL2 inhibitors - shaken and stirred. [PDF]

Haematologica
Bataller A, Issa GC.
europepmc   +1 more source

Wired to Survive: How AML Cytogenetics Shape Apoptotic Dependence and Venetoclax Resistance. [PDF]

Genes (Basel)
Rojas A, Jethi S, Budak-Alpdogan T, Pandey MK.   +3 more
europepmc   +1 more source

Current perspectives on KMT2A fusion proteins and menin inhibition in paediatric acute myeloid leukaemia. [PDF]

FEBS J
Roets LE, Greenfield G, Lappin KM.
europepmc   +1 more source

The new era of AML therapy: current standards and emerging targets. [PDF]

Int J Clin Oncol
Hosono N.
europepmc   +1 more source

TCA-controlled histone succinylation identifies IDH3B as a prognostic and therapeutic target in AML. [PDF]

Clin Epigenetics
Shi M, Yang K, Ding H, Zhao N, Ma J, Huang A, Wang Y, Zhu X, Iuso D, Gao M.   +9 more
europepmc   +1 more source